In NSCLC, the impaired mitochondrial oxidoreductive metabolism, which increases mitochondrial reactive oxygen species, activates the HIF-α/C/EBP-β axis that upregulates ABCC1 and downregulates ABCA1, producing chemo-immuno-resistance [10]. This evidence concerns the gene ABCA1 and non-small cell lung carcinoma.